Antti Mustonen1, Solja Niemelä2, Tanja Nordström1, Graham K Murray3, Pirjo Mäki4, Erika Jääskeläinen1, Jouko Miettunen1. 1. Center for Life Course Health Research,University of Oulu, Oulu, Finland and Medical Research Center Oulu, Oulu University Hospital and University of Oulu,Oulu,Finland. 2. Department of Psychiatry,Research Unit of Clinical Neuroscience,University of Oulu,Oulu, Finland and Department of Psychiatry,Lapland Hospital District, Rovaniemi,Finland. 3. Department of Psychiatry,University of Cambridge,Cambridge,UK. 4. Medical Research Center Oulu,Oulu University Hospital and University of Oulu,Oulu, Finland and Department of Psychiatry, Research Unit of Clinical Neuroscience, University of Oulu, Oulu, Finland and Department of Psychiatry, Oulu University Hospital, the Northern Ostrobothnia Hospital District, Oulu, Finland and Department of Psychiatry, Länsi-Pohja healthcare district, Finland and Department of Psychiatry, the Middle Ostrobothnia Central Hospital, Soite, Finland and Mental health services, Joint Municipal Authority of Wellbeing in Raahe District, Finland and Mental Health Services, Basic Health Care District of Kallio,Finland.
Abstract
BACKGROUND: The association between cannabis use and the risk of psychosis has been studied extensively but the temporal order still remains controversial. Aims To examine the association between cannabis use in adolescence and the risk of psychosis after adjustment for prodromal symptoms and other potential confounders. METHOD: The sample (n = 6534) was composed of the prospective general population-based Northern Finland Birth Cohort of 1986. Information on prodromal symptoms of psychosis and cannabis use was collected using questionnaires at age 15-16 years. Participants were followed up for ICD-10 psychotic disorders until age 30 years using nationwide registers. RESULTS: The risk of psychosis was elevated in individuals who had tried cannabis five times or more (hazard ratio, (HR) = 6.5, 95% CI 3.0-13.9). The association remained statistically significant even when adjusted for prodromal symptoms, other substance use and parental psychosis (HR = 3.0, 95% CI 1.1-8.0). CONCLUSIONS: Adolescent cannabis use is associated with increased risk of psychosis even after adjustment for baseline prodromal symptoms, parental psychosis and other substance use. Declaration of interest None.
BACKGROUND: The association between cannabis use and the risk of psychosis has been studied extensively but the temporal order still remains controversial. Aims To examine the association between cannabis use in adolescence and the risk of psychosis after adjustment for prodromal symptoms and other potential confounders. METHOD: The sample (n = 6534) was composed of the prospective general population-based Northern Finland Birth Cohort of 1986. Information on prodromal symptoms of psychosis and cannabis use was collected using questionnaires at age 15-16 years. Participants were followed up for ICD-10 psychotic disorders until age 30 years using nationwide registers. RESULTS: The risk of psychosis was elevated in individuals who had tried cannabis five times or more (hazard ratio, (HR) = 6.5, 95% CI 3.0-13.9). The association remained statistically significant even when adjusted for prodromal symptoms, other substance use and parental psychosis (HR = 3.0, 95% CI 1.1-8.0). CONCLUSIONS: Adolescent cannabis use is associated with increased risk of psychosis even after adjustment for baseline prodromal symptoms, parental psychosis and other substance use. Declaration of interest None.
Authors: Adina S Fischer; Susan F Tapert; Dexter Lee Louie; Alan F Schatzberg; Manpreet K Singh Journal: Curr Treat Options Psychiatry Date: 2020-04-18
Authors: Victoria Rodriguez; Luis Alameda; Giulia Trotta; Edoardo Spinazzola; Paolo Marino; Sandra L Matheson; Kristin R Laurens; Robin M Murray; Evangelos Vassos Journal: Schizophr Bull Date: 2021-07-08 Impact factor: 9.306